FDA Inspection
Innocore Sales & Marketing Inc.Innocore Sales & Marketing Inc. – FDA Inspection, Apr 25, 2025
Record Details
This FDA Inspection record concerns Innocore Sales & Marketing Inc., with an inspection on April 25, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · ae6fd99b-0ce3-42ad-8315-ab6adb26f0e3
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1267971
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
14- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.101(d)Component addition checked by 2nd person
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.65(a)Equipment construction - reactive surfaces
- 21 CFR 211.25(a)GMP Training Frequency
- 21 CFR 211.194(a)(4)Complete Test Data
- 21 CFR 211.186(b)(8)Description of containers, labels, et. al.
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.165(e)Test methods
- 21 CFR 211.84(d)(1)Identity Testing of Each Component
Showing 10 of 14 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Innocore Sales & Marketing Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 6, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Innocore Sales & Marketing Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.